Here is what I found
Bone mineral density and Turnover After Sleeve Gastrectomy and Gastric Bypass: A Randomized Controlled Trial (Oseberg)
Serious hypersensitivity reactions including anaphylaxis and angioedema have been reported with Ozempic Warnings and Precautions Risk of Thyroid C-Cell Tumors: Patients should be further evaluated if serum calcitonin is measured and found to be elevated or thyroid nodules are noted on physical examination or neck imaging Acute Pancreatitis: Acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis, has been observed in patients treated with GLP-1 receptor agonists, including semaglutide
Alogliptin is currently the only DPP-4 inhibitor in the U.S
This highlights the importance of proactive management in clinical practice, as these events, while generally not severe, carry significant clinical relevance
The astute reader may have noticed that a lot of these past studies were conducted using GLP1R agonists with much shorter half-lives (GLP1 = 5 minutes, Exenatide = 2 hours, Liraglutide = 13 hours)